Compare TDW & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TDW | RLAY |
|---|---|---|
| Founded | 1956 | 2015 |
| Country | United States | United States |
| Employees | 7300 | N/A |
| Industry | Marine Transportation | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3B | 4.1B |
| IPO Year | N/A | 2020 |
| Metric | TDW | RLAY |
|---|---|---|
| Price | $78.25 | $18.35 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 10 |
| Target Price | ★ $81.33 | $19.50 |
| AVG Volume (30 Days) | 651.6K | ★ 3.5M |
| Earning Date | 05-04-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 31.78 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $15,355,000.00 |
| Revenue This Year | $8.44 | N/A |
| Revenue Next Year | $12.34 | $324.03 |
| P/E Ratio | $24.08 | ★ N/A |
| Revenue Growth | N/A | ★ 53.44 |
| 52 Week Low | $46.65 | $3.03 |
| 52 Week High | $93.13 | $20.79 |
| Indicator | TDW | RLAY |
|---|---|---|
| Relative Strength Index (RSI) | 62.88 | 50.31 |
| Support Level | $76.82 | $6.67 |
| Resistance Level | $88.24 | $20.79 |
| Average True Range (ATR) | 2.75 | 1.20 |
| MACD | 0.89 | -0.28 |
| Stochastic Oscillator | 88.16 | 1.99 |
Tidewater Inc provides marine and transportation services to the offshore energy industry. The company's vessels and associated services support all phases of offshore crude oil and natural gas (also referred to as oil and gas) exploration activities, field development, production, and maintenance, as well as windfarm development and maintenance. Its services include towing and anchor handling for mobile offshore drilling units; transporting supplies and personnel necessary to sustain drilling, workovers, production activities, field abandonment, dismantlement, and restoration activities; and Others. The group manages its business through five segments, including the Americas, Asia Pacific, Middle East, Europe/Mediterranean, and West Africa.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process and bringing life-changing therapies to patients. The Dynamo platform of the company integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-8186, RLY-2608, RLY-4008 and others.